Who owns IONIS PHARMACEUTICALS INC?
- CUSIP Number: 462222af7
Tip: Access positions for across all investors
Analyze quarterly positions in Ionis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ionis Pharmaceuticals stock
Who bought or sold IONIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 96M | $153M | 0% | Dec 2025 |
|
| Deerfield Management Company | 60M | $95M | 0% | Dec 2025 |
|
| Camden Asset Management | 48M | $76B | 0% | Dec 2025 |
|
| Wellington Management Company | 28M | $39M | -3% | Sep 2025 |
|
| LMR Partners | 27M | $43M | 100% | Dec 2025 |
|
| DLD Asset Management | 27M | $42M | 6% | Dec 2025 |
|
| Lazard Asset Management | 24M | $378k | -36% | Dec 2025 |
|
| Linden Advisors | 20M | $32M | 0% | Dec 2025 |
|
| BlackRock | 17M | $28M | -31% | Dec 2025 |
|
| Calamos Advisors | 13M | $21M | -49% | Dec 2025 |
|
| State Street Corporation | 12M | $19M | 0% | Dec 2025 |
|
| MacKay Shields | 10M | $17M | -63% | Dec 2025 |
|
| Aristeia Capital | 10M | $16M | 100% | Dec 2025 |
|
| Royal Bank of Canada | 8.0M | $11M | 15% | Sep 2025 |
|
| FMR | 7.0M | $9.7M | -4% | Sep 2025 |
|
| M&G | 6.3M | $10M | 0% | Dec 2025 |
|
| Leucadia National Corporation | 5.3M | $8.5M | 100% | Dec 2025 |
|
| Colony | 5.3M | $8.3M | 100% | Dec 2025 |
|
| Sonora Investment Management Group | 5.3M | $7.3M | 0% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 5.1M | $8.2M | -57% | Dec 2025 |
|
| Advent Capital Management | 5.1M | $8.1M | -45% | Dec 2025 |
|
| Lord, Abbett & Co | 4.5M | $7.1M | 100% | Dec 2025 |
|
| CSS | 3.4M | $5.4M | -86% | Dec 2025 |
|
| Amundi | 3.2M | $508M | 100% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 3.1M | $5.0M | 25% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.8M | 0% | Dec 2025 |
|
| SSI Investment Management | 2.3M | $3.7M | 17% | Dec 2025 |
|
| Jpmorgan Chase & Co | 2.2M | $3.0M | 100% | Sep 2025 |
|
| Goldman Sachs Group | 2.0M | $3.2M | 147% | Dec 2025 |
|
| Westwood Holdings | 2.0M | $2.0M | 0% | Dec 2025 |
|
| Wolverine Asset Management | 1.9M | $3.0M | -93% | Dec 2025 |
|
| Barclays | 1.6M | $2.5M | 100% | Dec 2025 |
|
| Invesco | 1.5M | $2.4M | 100% | Dec 2025 |
|
| Wells Fargo & Company | 1.5M | $2.3M | -79% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 1.4M | $1.9M | 112% | Sep 2025 |
|
| Union Bancaire Privee, UBP SA | 1.3M | $1.8M | -7% | Dec 2025 |
|
| AXA Investment Managers | 935k | $612k | 100% | Sep 2025 |
|
| Agf Management | 750k | $1.2M | 100% | Dec 2025 |
|
| Palisade Capital Management | 500k | $691k | -50% | Sep 2025 |
|
| Man Group | 180k | $286k | -89% | Dec 2025 |
|
| Calamos Wealth Management | 145k | $231k | 1% | Dec 2025 |
|
| Sei Investments | 105k | $167k | -60% | Dec 2025 |
|
| Branch Banking & Trust Company | 73k | $119k | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 31k | $49k | -92% | Dec 2025 |
|
| Goss Wealth Management | 13k | $21k | 100% | Dec 2025 |
|
| Boussard & Gavaudan Investment Management | 13k | $20M | 100% | Dec 2025 |
|
| Nomura Holdings | 5.0k | $398k | -90% | Dec 2025 |
|
| Oddo Bhf Asset Management Sas | 374.00 | $595k | 100% | Dec 2025 |
|
Who sold out of Ionis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Sep 2025 | 9.0M | $12M |
| Tenor Capital Management | Jun 2025 | 8.0M | $8.4M |
| Shenkman Capital Management | Sep 2025 | 5.1M | $7.1B |
| RWC Asset Management | Sep 2025 | 2.4M | $3.3M |
| Deutsche Bank Aktiengesellschaft | Sep 2025 | 720k | $995k |
| Zurcher Kantonalbank | Sep 2025 | 500k | $691k |
| Lombard Odier Asset Management | Sep 2025 | 73k | $15M |
| UBS Group | Sep 2025 | 17k | $24k |